• Red Blood Cell Lysis Buffer: Selective Erythrocyte Removal f

  2026-06-10

  Red Blood Cell Lysis Buffer enables the selective lysis of erythrocytes in mammalian samples, preserving nucleated cells for downstream analysis. Its ammonium chloride-based formulation supports high-fidelity workflows for flow cytometry and molecular extraction, as validated in hematological research. The K1169 kit from APExBIO ensures consistency and reproducibility across immunological and molecular applications.

• FLOT1-FOSL2-EphA2 Axis Modulates Microglial Polarization in

  2026-06-10

  This study uncovers how the FLOT1-FOSL2 interaction drives EphA2 transcription to promote pro-inflammatory microglial polarization via p38/MAPK signaling in Alzheimer’s disease models. Targeting this pathway offers new insight into modulating neuroinflammation and cognitive decline in neurodegenerative disease research.

• Calpeptin as a Precision Tool: Beyond Fibrosis to Cell Commu

  2026-06-09

  Explore how Calpeptin, a potent calpain inhibitor, enables advanced research in cell differentiation, fibrosis, and extracellular vesicle biology. This article reveals mechanistic insights and offers new perspectives for pulmonary fibrosis and cancer studies.

• Morin: Applied Workflows for Mitochondrial and Fluorescent A

  2026-06-09

  Morin, a natural flavonoid antioxidant, empowers researchers with its dual action as a mitochondrial modulator and fluorescent aluminum ion probe. Explore advanced workflows, troubleshooting strategies, and data-driven insights that differentiate Morin's application in disease modeling and bioanalytical detection.

• NET Formation in CML: Differential Modulation by TKIs

  2026-06-08

  This study demonstrates that chronic myeloid leukemia (CML) is associated with elevated neutrophil extracellular trap (NET) formation, and that tyrosine kinase inhibitors (TKIs) modulate this process in distinct ways. The findings highlight a potential mechanistic link between CML therapies and vascular toxicity, informing translational research and future clinical strategies.

• Strategic Advances with YM-155 Hydrochloride in Translationa

  2026-06-08

  This article delivers a thought-leadership analysis of YM-155 hydrochloride, bridging the mechanistic rationale of survivin inhibition with actionable guidance for translational cancer researchers. We integrate mechanistic insights, workflow recommendations, and in vitro evaluation strategies—grounded in literature and advanced by the latest methodological developments—to elevate apoptosis inhibitor research and tumor regression studies in models such as NSCLC and TNBC.

• Caspase-3 Fluorometric Assay Kit: Quantitative Apoptosis Ana

  2026-06-07

  The Caspase-3 Fluorometric Assay Kit enables sensitive, quantitative detection of cysteine-dependent aspartate-directed protease (caspase-3) activity in cell lysates. This assay provides rapid, reproducible measurement of apoptosis-associated enzymatic events, supporting rigorous apoptosis research and pathway analysis.

• Leveraging PTH (1-34) for Translational Models of Bone–Kidne

  2026-06-06

  This article offers mechanistic insight and strategic guidance for optimizing translational research on the bone–kidney axis using Parathyroid hormone (1-34) (human). It connects the latest findings in CKD-driven valvular calcification to advanced experimental workflows, highlighting APExBIO's reagent as a linchpin for modeling, protocol design, and reproducibility.

• 4-Hydroxytamoxifen: Technical Use Guidance for Lab Research

  2026-06-05

  4-Hydroxytamoxifen (SKU B6167) is a high-purity estrogen receptor modulator designed for research in breast and prostate cancer, apoptosis assays, and cardiac myocyte calcium handling studies where DMSO solubility is required. It is not compatible with aqueous or ethanol-based workflows, and improper handling or storage can compromise experimental reproducibility.

• FLNa Suppression Unlocks HEV Replication via NF-κB Pathway B

  2026-06-05

  This study reveals that hepatitis E virus (HEV) promotes its own replication by inhibiting filamin A (FLNa), which in turn blocks NF-κB nuclear translocation and disrupts host antiviral responses. The findings establish a mechanistic link between cytoskeletal remodeling and innate immunity evasion, providing a refined understanding relevant for pathway-targeted research.

• (1S,3R)-RSL3: Unraveling Ferroptosis via GPX4 Inhibition

  2026-06-04

  (1S,3R)-RSL3 is a potent glutathione peroxidase 4 inhibitor driving ferroptosis in advanced cancer research. This article explores how RSL3 enables deeper insights into oxidative stress, synthetic lethality, and the underappreciated execution phase of ferroptotic cell death.

• Morin: Protocols, Bioanalytical Workflows, and Troubleshooti

  2026-06-04

  Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one) stands out as a multifunctional research tool, uniquely bridging mitochondrial metabolic modulation and fluorescence-based detection in disease models. This guide delivers actionable protocol enhancements, troubleshooting insights, and a critical analysis of the latest mechanistic advances.

• p-Cresyl Sulfate in Endothelial Dysfunction & Calcification

  2026-06-03

  p-Cresyl sulfate, a key uremic toxin, is transforming cardiovascular and renal disease research by enabling reproducible modeling of endothelial dysfunction and valvular calcification. This guide details advanced assay workflows, troubleshooting strategies, and protocol optimizations for leveraging APExBIO's p-Cresyl sulfate in translational studies.

• Parathyroid hormone (1-34) (human) in Bone and Kidney Resear

  2026-06-03

  Parathyroid hormone (1-34) (human) empowers high-fidelity studies of bone metabolism and kidney disease modeling, enabling reproducible, physiologically relevant workflows. Its robust receptor activation and solubility profile make it a gold standard for both in vitro and in vivo applications.

• AhR Activation Mitigates Acute Pancreatitis via RBX1/HSF1 Pa

  2026-06-02

  This study elucidates a novel mechanism by which aryl hydrocarbon receptor (AhR) activation attenuates acute pancreatitis (AP) through modulation of the RBX1/HSF1 axis. The findings clarify how AhR regulates macrophage polarization and tight junction integrity, offering mechanistic insights and potential therapeutic targets for severe AP.

15322 records 1/1022 page Next 12345 下5页 Last page